Patent · US Active

Peptide conjugated particles for the treatment of inflammation

US11413337B2 · kind B2 · utility

1Cited by
8References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2019
Grant dateAug 16, 2022
Priority date
Expiry dateMar 21, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/6093
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions comprising peptide-coupled biodegradable poly(lactide-co-glycolide) (PLG) particles. In particular, PLG particles are surface-functionalized to allow for coupling of peptide molecules to the surface of the particles (e.g., for use in eliciting induction of immunological tolerance).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.